29 September 2019 in Ear, Nose & Throat Journal
Previous studies reported that positive airway pressure (PAP) treatment may improve olfaction function in patients with obstructive sleep apnea (OSA) through various mechanisms. Olfactory function before and after PAP treatment is understudied regarding patient group at issue. The aim of this study is to investigate the contribution of PAP to olfactory function in patients with OSA. The study was conducted on 26 patients with OSA (10 females and 16 males, mean age 50.1 [9.3] years) who scheduled for PAP treatment. The Connecticut Chemosensory Clinical Research Center odor test was performed before and 4 months after PAP treatment. Patients were grouped (normal, anosmia, mild hyposmia, moderate hyposmia, and severe hyposmia) with respect to olfactory function by measuring odor test parameters, including threshold determination and identification. The odor test average scores of the patients after 4-month PAP treatment compared to pretreatment scores were increased and the difference was statistically significant (P = .002). In the apnea hypopnea index groups, statistically significant difference was found in the threshold and discrimination values regarding before PAP treatment (P = .038, P = .022, respectively). This study revealed that improvement in olfactory thresholds in patients with OSA receiving PAP treatment seems to improve olfactory dysfunction. This provides minimization of OSA consequences, including progressive upper airway inflammation, cognitive impairment, and associated olfactory dysfunction. Resolving the associations between olfactory function and PAP treatment is an important area for future research.
6 November 2017 in Brazilian Journal of Otorhinolaryngology
Although the nose and lungs are separate organs, numerous studies have reported that the entire respiratory system can be considered as a single anatomical and functional unit. The upper and lower airways affect each other either directly or through reflex mechanisms. In this study, we aimed to evaluate the effects of the radiofrequency ablation of persistent inferior turbinate hypertrophy on nasal and pulmonary function. Twenty-seven patients with bilateral persistent inferior turbinate hypertrophy without septal deviation were included in this study. All of the patients were evaluated using anterior rhinoscopy, nasal endoscopy, acoustic rhinometry, a visual analogue scale, and flow-sensitive spirometry on the day before and 4 months after the radiofrequency ablation procedure. The post-ablation measurements revealed that the inferior turbinate ablation caused an increase in the mean cross-sectional area and volume of the nose, as well as in the forced expiratory volume in 1s, forced vital capacity, and peak expiratory flow of the patients. These differences between the pre- and post-ablation results were statistically significant. The post-ablation visual analogue scale scores were lower when compared with the pre-ablation scores, and this difference was also statistically significant. This study demonstrated that the widening of the nasal passage after the reduction of the inferior turbinate size had a favorable effect on the pulmonary function tests.
1 March 2016 in Ear, Nose & Throat Journal
The aim of this study was to investigate the presence of Helicobacter pylori in human lacrimal and nasal secretions. Eighty patients with complaints of dyspepsia who had undergone endoscopies and gastric antrum biopsies were included in the study. A total of five specimens, including 2 lacrimal secretion samples, 2 nasal mucosal swab samples, and 1 gastric antrum biopsy, were collected from each patient and investigated with polymerase chain reaction (PCR) methods consisting of the urease enzyme coding gene GlmM (UreC) and the H pylori-specific 16S rRNA coding gene. The Reflux Symptom Index and ophthalmologic complaints of the patients were recorded. The detected positivity rates of the H pylori 16S rRNA coding gene in gastric biopsies and nasal mucous and lacrimal secretions were 55, 11.2, and 20%, respectively. The patients were grouped as gastric-antrum-biopsy–negative (Group I [n = 36]) and –positive (Group II [n = 44). In Group II, H pylori positivity in the lacrimal and nasal mucous secretions was 36.3 and 18%, respectively. A comparison between the groups in terms of H pylori presence in nasal mucous and lacrimal secretions yielded statistically significant differences (p = 0.0001, p = 0.003). The simultaneous presence of H pylori in nasal mucous and lacrimal secretions was 13.6% in Group II. H pylori positivity in nasal mucous and lacrimal secretions had a positive moderate correlation (r = 0.40; p = 0.0003). The present study is the first report on the presence of H pylori in lacrimal secretions through nested PCR, which suggested the presence of a number of mechanisms for H pylori transmission to lacrimal secretions.
20 November 2024 in Turkish Archives of Otorhinolaryngology
An Unusual Acute Otitis Media Complication: Luc’s Abscess - Turkish Archives of Otorhinolaryngology
1 August 2025 in Journal of Surgery and Medicine
Sudden hearing loss (SHL) is a clinical condition characterized by the acute onset of sensorineural hearing loss. Although many etiological factors have been reported, it is primarily idiopathic. Idiopathic Intracranial Hypertension (IIH) is a syndrome that presents signs of increased intracranial pressure in the absence of any intracranial lesion, meningeal inflammation, or venous obstruction. In our case, a patient diagnosed with SHL presented with hearing loss and visual field constriction. An investigation into etiological factors identified IIH. Although rare, IIH can cause SHL. It is crucial to consider this possibility during the diagnostic process and carefully plan the treatment based on the potential etiology.
6 January 2026 in Journal of Surgery and Medicine
Background/Aim: Nasal septum deviation (NSD) is a prevalent cause of nasal obstruction, significantly impairing quality of life. Although various subjective and objective assessment tools exist, the correlation between these methods remains insufficiently investigated. This study aimed to evaluate the relationship between septal deviation morphology and peak nasal inspiratory flow (PNIF) measurements, and to determine the correlation between objective PNIF values and subjective Nasal Obstruction Symptom Evaluation (NOSE) scores. Methods: Between July and September 2023, 52 patients diagnosed with NSD and nasal obstruction, along with 20 healthy controls, were enrolled. Patients were classified into three groups (A, B, and C) based on the degree of nasal obstruction. PNIF measurements and NOSE scores were obtained from all participants. Results: The mean NOSE score and PNIF value in the study group were 59.33 (27.19) and 76.73 (38.76) l/min, respectively, while the mean PNIF value in the control group was 145.5 (17.01) l/min. Statistically significant differences were found in PNIF and NOSE scores between groups. A strong correlation was observed between PNIF and NOSE scores (P=0.004). Conclusion: The combined use of objective PNIF measurements and subjective NOSE assessments offers a comprehensive evaluation of nasal obstruction due to septal deviation, improving diagnostic accuracy and clinical decision-making.